Julia Robinson is our clinical and science editor/
The 100,000 Genome Project is driving the move from a ‘one size fits all’ approach to treatment, towards personalised, or precision, medicine. Genetic information is also being used by pharmaceutical companies to help speed up drug discovery and development, and reduce the associated costs. Pharmacists will have an important role to play when genomic medicine goes mainstream.
The number of children and young people with type 2 diabetes being managed in paediatric diabetes units has increased each year for the past three years, according to a national audit.
General practice-based HIV screening is an important public health intervention which should be used more widely, according to a study led by researchers at Queen Mary University of London and the London School of Hygiene and Tropical Medicine
Recent blog posts
Julia Robinson reports from a meeting discussing the implications of Brexit on UK pharmacovigilance.
The Royal Pharmaceutical Society has had a busy and challenging year. Julia Robinson describes the most popular ‘Your RPS’ articles of 2016.
A round up from RPS representatives from this year’s UK political party conferences.